54 results
8-K
EX-99.1
ME
23andMe Holding Co - Ordinary Shares
7 Feb 24
23andMe Reports Third Quarter Fiscal 2024 Financial Results
4:03pm
partially offset by higher revenue from non-recurring payments from other research partners as well as growth in our membership services revenue … in the quarter. The foregoing increase was partially offset by lower personnel-related expenses following workforce reductions in prior quarters along
8-K/A
ME
23andMe Holding Co - Ordinary Shares
1 Dec 23
Regulation FD Disclosure
4:06pm
of the costs and related impacts of this incident and related litigation, including, without limitation, the availability of insurance to offset some
8-K
EX-99.1
ME
23andMe Holding Co - Ordinary Shares
8 Nov 23
23andMe Reports Second Quarter Fiscal 2024 Financial Results
4:29pm
discounting, resulting in lower volumes of personal genome service (PGS) kit sales and telehealth orders. This was partially offset by growth in our … in August 2023, partially offset by continued investment in Therapeutics portfolio advancement and one-time expenses related to the workforce reduction
8-K
EX-99.1
vj4h213r0uo
8 Aug 23
23andMe Reports FY2024 First Quarter Financial Results
4:10pm
DEFR14A
ktqeo64 yt7
26 Jul 23
Revised proxy
9:14pm
8-K
EX-99.1
qeiuhecf
25 May 23
23andMe Reports FY2023 Fourth Quarter and Full Year Financial Results
4:08pm
8-K
EX-10.1
necf8lvn2wm9stxfqg
9 Dec 22
Departure of Directors or Certain Officers
8:05am
424B3
uxerjripiywtcxxp53hf
7 Nov 22
Prospectus supplement
4:33pm
8-K
EX-99.1
t52ssv40dx w3e
7 Nov 22
23andMe Reports FY2023 Second Quarter Financial Results
4:06pm
424B3
xl1wl1sckj
16 Aug 22
Prospectus supplement
6:12pm
8-K
EX-99.1
55micosl4vs
8 Aug 22
23andMe Reports FY2023 First Quarter Financial Results
4:14pm
DEF 14A
b6o9jtfvm ylm0jjs7ku
15 Jul 22
Definitive proxy
8:05am
424B3
v3jywx r3xoif6dd9z
27 May 22
Prospectus supplement
4:52pm